Related Experiment Video
Updated: Jun 5, 2026
Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
[Study on inhibitory effects of allicin in mucoepidermoid carcinoma cells]
Fayin Wu1, Qiong Chen, Hefeng Zhou
1Department of Stomatology, Fifth Affiliated Hospital, Zunyi Medical College, Zhuhai 519100, China. wfy660505@sina.com
Objective:
To observe the anticancer mechanism of allicin by observing the inhibitory effect of allicin on human salivary gland carcinoma cell line MEC-1.
Method:
Cell proliferation were measured by MTT assay at different doses and different hours. In the meantime, cell cycle was detected via flow cytometry after different dose incubation with different hours.
Result:
MTT results showed that the inhibitory rates of MEC-1 proliferations were increased in a concentration-and time-dependent manner. Flow cytometry analysis showed percent-age of MEC-1 cells decreased in G0/G1 phase and increased in G2/M. But there was no evident change in S phase. The cells were mainly blocked in M phase, and the inhibitory effect of the allicin on MEC-1 cells increased with the increasing of concentration and time.
Conclusion:
Allicin can inhibit the growth of MEC-1 cells in vitro dramatically.
Insights
Allicin effectively inhibits human salivary gland carcinoma MEC-1 cell growth. This natural compound demonstrated a concentration- and time-dependent reduction in cell proliferation and induced cell cycle arrest.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Salivary gland carcinoma is a rare malignancy with limited treatment options.
- Allicin, a compound found in garlic, exhibits potential anticancer properties.
- Understanding the specific mechanisms of allicin's action is crucial for therapeutic development.
Purpose of the Study:
- To investigate the anticancer effects of allicin on the human salivary gland carcinoma cell line MEC-1.
- To elucidate the mechanism by which allicin inhibits MEC-1 cell proliferation.
Main Methods:
- Cell proliferation was assessed using the MTT assay at various concentrations and time points.
- Cell cycle distribution was analyzed by flow cytometry following allicin treatment.
Main Results:
- Allicin demonstrated a significant, dose- and time-dependent inhibition of MEC-1 cell proliferation.
- Flow cytometry revealed a decrease in G0/G1 phase cells and an increase in G2/M phase cells, indicating cell cycle arrest.
- A notable accumulation of MEC-1 cells in the M phase was observed, suggesting a primary mechanism of action.
Conclusions:
- Allicin exhibits potent in vitro anticancer activity against human salivary gland carcinoma MEC-1 cells.
- The observed inhibition of cell growth is mediated by cell cycle arrest, primarily in the M phase.
- Allicin represents a promising candidate for further investigation as a therapeutic agent for salivary gland carcinoma.
